Laurel L. Ballantyne

516 total citations
17 papers, 400 citations indexed

About

Laurel L. Ballantyne is a scholar working on Molecular Biology, Genetics and Biochemistry. According to data from OpenAlex, Laurel L. Ballantyne has authored 17 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Genetics and 6 papers in Biochemistry. Recurrent topics in Laurel L. Ballantyne's work include Amino Acid Enzymes and Metabolism (4 papers), Metabolism and Genetic Disorders (4 papers) and Inflammatory mediators and NSAID effects (4 papers). Laurel L. Ballantyne is often cited by papers focused on Amino Acid Enzymes and Metabolism (4 papers), Metabolism and Genetic Disorders (4 papers) and Inflammatory mediators and NSAID effects (4 papers). Laurel L. Ballantyne collaborates with scholars based in Canada, United States and Australia. Laurel L. Ballantyne's co-authors include Colin Funk, Xinzhi Li, Ying Yu, Yuan Yan Sin, Garret A. FitzGerald, Derek A. Pratt, Alma Barajas‐Espinosa, Jeffrey Mewburn, Yan Dong and Andreas Schulze and has published in prestigious journals such as PLoS ONE, Scientific Reports and The FASEB Journal.

In The Last Decade

Laurel L. Ballantyne

17 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laurel L. Ballantyne Canada 12 199 83 79 65 60 17 400
Matteo Tardelli Austria 15 149 0.7× 94 1.1× 46 0.6× 37 0.6× 114 1.9× 26 713
Gloria Torres Chile 10 406 2.0× 116 1.4× 76 1.0× 63 1.0× 23 0.4× 11 664
Hiroto Tsukano Japan 5 213 1.1× 75 0.9× 81 1.0× 87 1.3× 27 0.5× 6 457
Khanichi N. Charles United States 5 240 1.2× 94 1.1× 28 0.4× 115 1.8× 30 0.5× 5 493
Bochra Tourki United States 10 132 0.7× 50 0.6× 101 1.3× 62 1.0× 43 0.7× 15 296
Tetsuya Kibe Japan 10 262 1.3× 158 1.9× 37 0.5× 31 0.5× 28 0.5× 23 484
Shigeki Tazawa Japan 10 204 1.0× 53 0.6× 53 0.7× 31 0.5× 30 0.5× 19 469
Waltraud Paßlack Germany 11 234 1.2× 121 1.5× 47 0.6× 24 0.4× 25 0.4× 18 458
Wanli Cheng United States 6 425 2.1× 199 2.4× 71 0.9× 118 1.8× 91 1.5× 9 734
Jin Wei China 9 253 1.3× 35 0.4× 105 1.3× 29 0.4× 21 0.3× 16 434

Countries citing papers authored by Laurel L. Ballantyne

Since Specialization
Citations

This map shows the geographic impact of Laurel L. Ballantyne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurel L. Ballantyne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurel L. Ballantyne more than expected).

Fields of papers citing papers by Laurel L. Ballantyne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurel L. Ballantyne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurel L. Ballantyne. The network helps show where Laurel L. Ballantyne may publish in the future.

Co-authorship network of co-authors of Laurel L. Ballantyne

This figure shows the co-authorship network connecting the top 25 collaborators of Laurel L. Ballantyne. A scholar is included among the top collaborators of Laurel L. Ballantyne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurel L. Ballantyne. Laurel L. Ballantyne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Zhang, Yuxi, et al.. (2022). The extended effect of adsorbed damage-associated molecular patterns and Toll-like receptor 2 signaling on macrophage-material interactions. Frontiers in Bioengineering and Biotechnology. 10. 959512–959512. 5 indexed citations
3.
Ballantyne, Laurel L., et al.. (2021). Arginase-1 deficiency in neural cells does not contribute to neurodevelopment or functional outcomes after sciatic nerve injury. Neurochemistry International. 145. 104984–104984. 3 indexed citations
4.
Li, Xinzhi, Laurel L. Ballantyne, Ying Yu, & Colin Funk. (2019). Perivascular adipose tissue–derived extracellular vesicle miR‐221‐3p mediates vascular remodeling. The FASEB Journal. 33(11). 12704–12722. 100 indexed citations
5.
Li, Xinzhi, Liudmila L. Mazaleuskaya, Laurel L. Ballantyne, et al.. (2018). Differential compensation of two cyclooxygenases in renal homeostasis is independent of prostaglandin‐synthetic capacity under basal conditions. The FASEB Journal. 32(10). 5326–5337. 5 indexed citations
6.
Li, Xinzhi, et al.. (2018). Isoform-Specific Compensation of Cyclooxygenase (Ptgs) Genes during Implantation and Late-Stage Pregnancy. Scientific Reports. 8(1). 12097–12097. 14 indexed citations
7.
Sin, Yuan Yan, et al.. (2017). Transplantation of Gene-Edited Hepatocyte-like Cells Modestly Improves Survival of Arginase-1-Deficient Mice. Molecular Therapy — Nucleic Acids. 10. 122–130. 8 indexed citations
8.
Li, Xinzhi, Liudmila L. Mazaleuskaya, Chong Yuan, et al.. (2017). Flipping the cyclooxygenase (Ptgs) genes reveals isoform-specific compensatory functions ,. Journal of Lipid Research. 59(1). 89–101. 12 indexed citations
9.
Sin, Yuan Yan, et al.. (2017). Proof-of-Concept Gene Editing for the Murine Model of Inducible Arginase-1 Deficiency. Scientific Reports. 7(1). 2585–2585. 14 indexed citations
10.
Li, Xinzhi, Liudmila L. Mazaleuskaya, Laurel L. Ballantyne, et al.. (2017). Genomic and lipidomic analyses differentiate the compensatory roles of two COX isoforms during systemic inflammation in mice ,. Journal of Lipid Research. 59(1). 102–112. 22 indexed citations
11.
Ballantyne, Laurel L., Yuan Yan Sin, Osama Y. Al-Dirbashi, et al.. (2016). Liver-specific knockout of arginase-1 leads to a profound phenotype similar to inducible whole body arginase-1 deficiency. Molecular Genetics and Metabolism Reports. 9. 54–60. 21 indexed citations
12.
Ballantyne, Laurel L., Yuan Yan Sin, Steven Goossens, et al.. (2015). Strategies to Rescue the Consequences of Inducible Arginase-1 Deficiency in Mice. PLoS ONE. 10(5). e0125967–e0125967. 12 indexed citations
13.
Li, Xinzhi, Laurel L. Ballantyne, Jeffrey Mewburn, et al.. (2015). Endogenously Generated Omega‐3 Fatty Acids Attenuate Vascular Inflammation and Neointimal Hyperplasia by Interaction With Free Fatty Acid Receptor 4 in Mice. Journal of the American Heart Association. 4(4). 35 indexed citations
14.
Kinobe, Robert, Laurel L. Ballantyne, Nadya Romanova, et al.. (2014). Heme oxygenase-1 overexpression exacerbates heart failure with aging and pressure overload but is protective against isoproterenol-induced cardiomyopathy in mice. Cardiovascular Pathology. 23(4). 231–237. 35 indexed citations
15.
Ballantyne, Laurel L., et al.. (2013). Multiple-Site Activation of the Cysteinyl Leukotriene Receptor 2 Is Required for Exacerbation of Ischemia/Reperfusion Injury. Arteriosclerosis Thrombosis and Vascular Biology. 34(2). 321–330. 18 indexed citations
16.
Sin, Yuan Yan, et al.. (2013). Inducible Arginase 1 Deficiency in Mice Leads to Hyperargininemia and Altered Amino Acid Metabolism. PLoS ONE. 8(11). e80001–e80001. 37 indexed citations
17.
Dong, Yan, et al.. (2011). A Selective Cysteinyl Leukotriene Receptor 2 Antagonist Blocks Myocardial Ischemia/Reperfusion Injury and Vascular Permeability in Mice. Journal of Pharmacology and Experimental Therapeutics. 339(3). 768–778. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026